Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments

Publisher： Karger

E-ISSN： 1421-9913|60|2|57-66

ISSN： 0014-3022

Source： European Neurology, Vol.60, Iss.2, 2008-05, pp. : 57-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Motor Symptoms upon the Quality of Life of Patients with Parkinson’s Disease

By  

European Neurology, Vol. 57, Iss. 3, 2007-01 ,pp. : 161-165

Karger

Access to resources Recommend Favorite

When Do Levodopa Motor Fluctuations First Appear in Parkinson’s Disease?

By  

European Neurology, Vol. 63, Iss. 5, 2010-03 ,pp. : 257-266

Karger

Access to resources Recommend Favorite

Transient Disabling Dyskinesias: A Predictor of Good Outcome in Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

By  

European Neurology, Vol. 61, Iss. 2, 2008-11 ,pp. : 94-99

Karger

Access to resources Recommend Favorite

Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson’s Disease Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 32, Iss. 4, 2011-11 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

Five-Year Follow-Up of Early Lisuride and Levodopa Combination Therapy versus Levodopa Monotherapy in de novo Parkinson’s Disease

By  

European Neurology, Vol. 44, Iss. 1, 2000-07 ,pp. : 22-30

Karger

Access to resources Recommend Favorite